Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
2.
Experimental & Molecular Medicine ; : 574-582, 2007.
Article in English | WPRIM | ID: wpr-82952

ABSTRACT

Familial amyotrophic lateral sclerosis (fALS) is caused by mutations in Cu/Zn-superoxide dismutase (SOD1), and SOD1 aggregation and calcium toxicity are involved in neuronal death. However, the effect of altered calcium homeostasis on the SOD1 aggregation is unknown. To investigate whether calcium triggers mutant SOD1 aggregation in vitro, human mutant SOD1 (G93A) was transfected into motor neuronal cell line (VSC 4.1 cells). These cells were then treated with calcium ionophore A23187 or agents that induce intracellular calcium release like cyclic ADP ribose, ryanodine or thapsigargin. A23187 was found to increase mutant SOD1 aggregation and neuronal nitric oxide synthase (nNOS) expression. Moreover, the NOS inhibitor (L-NAME) and a NO-dependent cyclic GMP cascade inhibitor (ODQ) reduced SOD1 aggregation, whereas an exogenous NO donor (GSNO) increased mutant SOD1 aggregation, which was also prevented by NOS or cGMP cascade inhibitor. Our data demonstrate that calcium-influx increases SOD1 aggregation by upregulating NO in cultured motor neuronal cells.


Subject(s)
Animals , Humans , Rats , Amyotrophic Lateral Sclerosis/genetics , Calcimycin/pharmacology , Calcium/metabolism , Calpain/metabolism , Caspase 3/metabolism , Cell Line , Ionophores/pharmacology , Motor Neurons/metabolism , Multiprotein Complexes , Mutation , Nitric Oxide/metabolism , Recombinant Proteins/chemistry , Superoxide Dismutase/chemistry , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL